Concentration Risk Benchmark [Axis]
Revenue [Member]
Concentration Risk Type [Axis]
Geographic Concentration [Member]
Geographical [Axis]
USA [Member]
Asia [Member]
Europe [Member]
Japan [Member]
Business Acquisition [Axis]
TPSCo [Member]
Equity Components [Axis]
Ordinary shares [Member]
Additional paid-in capital [Member]
Capital notes [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Treasury stock [Member]
Unearned compensation [Member]
Foreign currency translation adjustments [Member]
Noncontrolling interest [Member]
Award Type [Axis]
RSU's [Member]
Comprehensive income (loss) [Member]
Retirement Plan Type [Axis]
Pension Plan [Member]
Postretirement Medicare Plan [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
Technologies [Member]
Trade name [Member]
Customer relationships [Member]
Technologies Two [Member]
Technologies One [Member]
Patents and other core technology rights [Member]
Facilities lease [Member]
Legal Entity [Axis]
Long-term Debt, Type [Axis]
Term Loan 2014[Member]
Term Loan 2015 [Member]
Counterparty Name [Axis]
Jazz [Member]
Related Party Transactions By Related Party [Axis]
TPSCo [Member]
Health Care Cost Trend Rates [Axis]
Post 65 [Member]
Pre 65 [Member]
Income Statement Location [Axis]
Cost of goods [Member]
Research and development, net [Member]
Marketing, general and administrative [Member]
Accounts Receivable [Member]
Customer [Axis]
Customer A [Member]
Customer B [Member]
Customer C [Member]
Customer One [Member]
Customer Two [Member]
Currency [Axis]
JPY [Member]
JA Mitsui Leasing Capital Corporation [Member]
Loan to TJT [Member]
Debt Instrument [Axis]
Debentures Series G [Member]
Israel, New Shekels INS [Member]
Plan Name [Axis]
2013 Plan [Member]
Title of Individual [Axis]
Employees and directors [Member]
Property, Plant and Equipment, Type [Axis]
Land and Buildings and building improvements, including facility infrastructure [Member]
Machinery and equipment, software and hardware [Member]
Others [Member]
Tower's loans (including current maturities) [Member]
U.S. Dollars [Member]
Jazz's Notes [Member]
Total outstanding principal amounts of debentures [Member]
Tower and Jazz Debentures [Member]
Consolidated Entities [Axis]
Tower US Holdings [Member]
Measurement Frequency [Axis]
Recurring [Member]
Fair Value, Hierarchy [Axis]
Level 1 [Member]
Level 2 [Member]
Level 3 [Member]
Old Plans [Member]
Israel [Member]
Financial Instrument [Axis]
Corporate Debentures [Member]
Tacoma [Member]
Chief Executive Officer [Member]
Time Vested Restricted Shares Units [Member]
Performance-based RSU's [Member]
Chairman of the board of directors [Member]
New other directors [Member]
Tower [Member]
Geographic Distribution [Axis]
Variable Rate [Axis]
Prime Rate [Member]
Range [Axis]
Minimum [Member]
Maximum [Member]
LIBOR [Member]
Certificate of deposits [Member]
Municipal bonds [Member]
Non- U.S government bonds [Member]
Total outstanding principal amounts of loans [Member]
Collateral [Axis]
Equity Securities [Member]
Debt Securities [Member]
Exercise Price Range [Axis]
$4.42- $17.25 [Member]
Income Tax Authority [Axis]
State and Local Jurisdiction [Member]
Major Customer Far East Region [Member]
Term Loan 2018 [Member]
U.S government bonds [Member]
Money market fund [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Postretirement Non Medical Plan [Member]
Vesting [Axis]
Third Anniversary [Member]
Second Anniversary [Member]
First Anniversary [Member]
Machinery and Equipment [Member]
Document and Entity Information [Abstract]
Document Type
Amendment Flag
Document Period End Date
Entity Registrant Name
Entity Central Index Key
Document Fiscal Year Focus
Document Fiscal Period Focus
Current Fiscal Year End Date
Statement of Financial Position [Abstract]
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Short-term interest-bearing deposits
Marketable securities
Trade accounts receivable
Inventories
Other current assets
Total current assets
LONG-TERM INVESTMENTS
PROPERTY AND EQUIPMENT, NET
INTANGIBLE ASSETS, NET
GOODWILL
DEFERRED TAX AND OTHER LONG-TERM ASSETS, NET
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Current maturities of loans, leases and debentures
Trade accounts payable
Deferred revenue and customers' advances
Employee related liabilities
Other current liabilities
Total current liabilities
LONG-TERM DEBT
Debentures
Other long-term debt
LONG-TERM CUSTOMERS' ADVANCES
EMPLOYEE RELATED LIABILITIES
DEFERRED TAX LIABILITY
OTHER LONG-TERM LIABILITIES
TOTAL LIABILITIES
Ordinary shares of NIS 15 par value: 150,000 authorized as of December 31, 2018 and 2017 105,066 and 104,980 issued and outstanding, respectively, as of December 31, 2018 98,544 and 98,458 issued and outstanding, respectively, as of December 31, 2017
Additional paid-in capital
Capital notes
Cumulative stock based compensation
Accumulated other comprehensive loss
Accumulated deficit
SHAREHOLDERS' EQUITY, before treasury stock
Treasury stock, at cost - 86 shares
THE COMPANY'S SHAREHOLDERS' EQUITY
Non-controlling interest
TOTAL SHAREHOLDERS' EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
Ordinary shares, par value
Ordinary shares, authorized
Ordinary shares, issued
Ordinary shares, outstanding
Treasury stock, shares
Income Statement [Abstract]
REVENUES
COST OF REVENUES
GROSS PROFIT
OPERATING COSTS AND EXPENSES:
Research and development
Marketing, general and administrative
Nishiwaki Fab restructuring and impairment cost (income), net
TOTAL OPERATING COSTS AND EXPENSES
OPERATING PROFIT
FINANCING EXPENSE, NET
GAIN FROM ACQUISITION, NET
OTHER INCOME (EXPENSE), NET
PROFIT BEFORE INCOME TAX
INCOME TAX BENEFIT (EXPENSE), NET
NET PROFIT
Net loss (income) attributable to non-controlling interest
NET PROFIT ATTRIBUTABLE TO THE COMPANY
BASIC EARNINGS PER ORDINARY SHARE:
Earnings per share
Weighted average number of ordinary shares outstanding
DILUTED EARNINGS PER ORDINARY SHARE:
Earnings per share
Net profit used for diluted earnings per share
Weighted average number of ordinary shares outstanding used for diluted earnings per share
Statement of Comprehensive Income [Abstract]
Net profit
Other comprehensive income, net of tax:
Foreign currency translation adjustment
Change in employees plan assets and benefit obligations, net of taxes in the amount of $81, $171 and $184 for the years ended December 31, 2018, 2017 and 2016, respectively
Unrealized loss on marketable securities
Unrealized gain (loss) on derivatives
Comprehensive income
Comprehensive (income) loss attributable to non-controlling interest
Comprehensive income attributable to the Company
Change in employees plan assets and benefit obligations, net of taxes
Statement [Table]
Statement [Line Items]
BALANCE
BALANCE, SHARES
Establishment of a subsidiary
Issuance of shares
Issuance of shares, shares
Conversion of debentures and exercise of warrants into share capital
Conversion of debentures and exercise of warrants into share capital, shares
Conversion of notes into share capital
Conversion of notes into share capital, shares
Exercise of options
Exercise of options, shares
Exercise of options and RSUs
Exercise of options and RSUs, shares
Employee stock-based compensation
Beneficial conversion feature
Capital notes converted into share capital
Capital notes converted into share capital, shares
Employee stock-based compensation
Stock-based compensation related to the Facility Agreement with the Banks
Tax benefit relating to stock based compensation
Dividend paid to Panasonic
Accumulated amount due to adoption of ASU No. 2016-09, Compensation - Stock Compensation (Topic 718)
Other comprehensive income:
Profit
Foreign currency translation adjustments
Change in employees plan assets and benefit obligations
Comprehensive income
BALANCE
BALANCE, SHARES
OUTSTANDING SHARES, NET OF TREASURY STOCK AS OF DECEMBER 31, 2018
Statement of Cash Flows [Abstract]
CASH FLOWS - OPERATING ACTIVITIES
Adjustments to reconcile net profit for the period to net cash provided by operating activities:
Income and expense items not involving cash flows:
Depreciation and amortization
Effect of indexation, translation and fair value measurement on debt
Other expense (income), net
Gain from acquisition, net
Changes in assets and liabilities:
Trade accounts receivable
Other current assets
Inventories
Trade accounts payable
Deferred revenue and customers' advances
Employee related liabilities and other current liabilities
Long-term employee related liabilities
Deferred tax, net
Other long-term liabilities
Net cash provided by operating activities
CASH FLOWS - INVESTING ACTIVITIES
Investments in property and equipment
Proceeds related to sale of property and equipment
Investment grants received
Investments in other assets
Deposits and marketable securities, net
Net cash used in investing activities
CASH FLOWS - FINANCING ACTIVITIES
Issuance of debentures, net
Exercise of warrants and options, net
Proceeds from loans, net
Loans repayment
Principal payments on account of capital lease obligation
Debentures repayment
Dividend paid to Panasonic
Net cash provided by (used in) financing activities
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGE
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS - END OF PERIOD
NON-CASH ACTIVITIES:
Investments in property and equipment
Conversion of notes into share capital
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest
Cash received during the period from interest
Cash paid during the period for income taxes, net
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS AND GENERAL
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Inventory Disclosure [Abstract]
INVENTORIES
Prepaid Expense and Other Assets, Current [Abstract]
OTHER CURRENT ASSETS
Investments, Debt and Equity Securities [Abstract]
LONG-TERM INVESTMENTS
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET
Intangible Assets, Net (Excluding Goodwill) [Abstract]
INTANGIBLE ASSETS, NET
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
DEFERRED TAX AND OTHER LONG-TERM ASSETS, NET
Other Liabilities, Current [Abstract]
OTHER CURRENT LIABILITIES
Notes Payable [Abstract]
DEBENTURES
Loans Payable [Abstract]
OTHER LONG-TERM DEBT
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURMENTS
Postemployment Benefits [Abstract]
EMPLOYEE RELATED LIABILITIES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Stockholders' Equity Note [Abstract]
SHAREHOLDERS' EQUITY
Segment Reporting [Abstract]
INFORMATION ON GEOGRAPHIC AREAS AND MAJOR CUSTOMERS
Other Income and Expenses [Abstract]
FINANCING EXPENSE, NET
Income Tax Disclosure [Abstract]
INCOME TAXES
Related Party Transactions [Abstract]
RELATED PARTIES BALANCES AND TRANSACTIONS
Use of Estimates in Preparation of Financial Statements
Principles of Consolidation
Cash and Cash Equivalents
Short-Term Interest-Bearing Deposits
Marketable securities
Trade Accounts Receivables - Allowance for Doubtful Accounts
Inventories
Property and Equipment
Intangible Assets and Goodwill
Deferred Tax Asset and Other Long-Term Assets, Net
Debentures - Classification of Liabilities and Equity of Convertible Debentures
Stock-Based Instruments in Financing Transactions
Revenue Recognition
Research and Development
Income Taxes
Earnings Per Ordinary Share
Comprehensive Income
Functional Currency and Exchange Rate Income (Loss)
Stock-Based Compensation
Impairment of Assets
Classification of Liabilities and Equity
Fair value of Financial Instruments and Fair Value Measurements
Derivatives and hedging
Accounts Receivable Factoring
Reclassification and Presentation
Recently Adopted Accounting Pronouncements
Recently Issued Accounting Pronouncements
Schedule of Estimated Economic Lives
Summary of Effect on Equity and Retained Earnings
Schedule of Inventory
Summary of Other Current Assets
Schedule of Long-Term Investments
Schedule of Property and Equipment
Schedule of Leased Property Under Capital Leases
Schedule of Intangible Assets, Net
Schedule of Deferred Tax and Other Long-Term Assets
Schedule of Other Current Liabilities
Schedule of Maturities of Debentures
Schedule of Debenture Fair Value and Allocation of Proceeds
Schedule of Other Long-Term Debt
Schedule of Repayment of Loans
Schedule of Recurring Fair Value Measurements
Schedule of Liabilities Measured on a Recurring Basis Using Significant Unobservable Inputs
Schedule of Marketable Securities
Schedule of Maturities of Marketable Securities
Schedule of Investments with Continuous Unrealized Losses
Schedule of Defined Benefit Plans Disclosures [Table]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Net Periodic Benefit Cost
Schedule of Amounts Recognized in Other Comprehensive Income
Schedule of Estimated Amounts in Accumulated Other Comprehensive Income to be Recognized over the Next Fiscal Year
Schedule of Impact of One-Percentage-Point Change in Assumed Health Care Cost
Schedule of changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status
Schedule of Amounts Recognized in Statement of Financial Position
Schedule of Future Benefit Payments
Schedule of Weighted Average Assumptions Used
Schedule of Health Care Cost Trend Rates
Schedule of Weighted Average Asset Allocations
Schedule of Assets Measured at Fair Value on a Recurring Basis
Schedule of Share Option Activity
Schedule of Restricted Shares Units Activity
Schedule of Information about Share Options Outstanding
Schedule of Intrinsic and Fair Values for Options Exercised
Schedule of Intrinsic and Fair Values for RSU's Exercised
Schedule of Key Information for Option Plans
Schedule of Stock-Based Compensation Expense in Statement of Operations
Schedule of Fair Value of Options Granted
Schedule of Revenues by Geographic Area
Schedule of Long-Lived Assets by Geographic Area
Schedule of Accounts Receivable of Major Customers
Schedule of Revenues of Major Customers
Schedule of Financing Expense
Schedule of Income Tax Provision
Schedule of Profit (Loss) Before Taxes
Schedule of Deferred Tax Asset/Liability
Schedule of Reconciliation of Unrecognized Tax Benefits
Schedule of Effective Income Tax Rate Reconciliation
Schedule of Related Party Balances and Transactions
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Percentage of interests acquired
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for doubtful account
Property and equipment, estimated economic life
Raw materials
Work in process
Finished goods
Inventory, net, total
Aggregate inventory write-downs
Tax receivables
Prepaid expenses
Interest on deposits and other receivables
Other current assets
LONG-TERM INVESTMENTS [Abstract]
Severance-pay funds, net
Long-term interest bearing bank deposit
Others
Long-term investments, total
Reduction in depreciation expenses
Increase in profit
Investment grants
Estimated useful lives
Aggregate investment grants received
Decrease in basic loss per share due to extension of estimated useful lives
Original cost:
Accumulated depreciation
Property and equipment, net
Original cost - machinery and equipment
Accumulated depreciation - machinery and equipment
Total, net
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Life
Cost
Accumulated Amortization
Net
Deferred tax asset (see Note 18)
Prepaid long-term land lease, net (see Note 14C)
Fair value of cross currency interest rate swap (see Note 12D)
Long-term prepaid expenses and others
Deferred tax and other assets, net
Tax payables
Interest payable
Others
Total other current liabilities
Schedule of Long-term Debt Instruments [Table]
Debt Instrument [Line Items]
Issuance date
Maturity date
Outstanding principal
Proceeds from non-convertible debentures
Principal amount
Interest rate
Number of installment payments
Conversion ratio per share
Number of shares issued from conversion
Repurchase amount
Accretion and amortization
Redemption premium (as a percent)
Hedging transactions asset fair value
Repayment schedule (carrying amount):
2018
2019
2020
2021
2022
2023
Total
Accretion of carrying amount to principal amount
Carrying amount
Effective interest rate
Total long-term loan - principal amount
Fair value adjustments
Deferred issuance costs
Total long-term loans
Capital leases
Less - current maturities
Fair value
Interest rate
2022 and on
2023 and on
Line of Credit Facility [Line Items]
Term
Maximum borrowing amount
Borrowing availability
Basis spread over variable interest rate
Borrowing capacity
Borrowing utilized amount
Amount outstanding
Letters of credit outstanding amount
Maturity term
Outstanding principal
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of debentures
Carrying amount
Fair value liability face amount
Fair value of swap in asset position
Fair value of swap in short-term assets
Fair value of swap in short-term liabilities
Fair value of swap
Fair value of swap in long-term asset
Fair value of swap in liability position (short term)
Effective portion of unrealized gains recorded in OCI
Fair value of derivative liabilities
Fair value of derivative assets
Gain (loss) of hedge on operations
Amount of loss expected to be reclassified into earnings currently recorded as other comprehensive income, as a result of the maturity of currently held forward exchange contracts
Long term bank deposit amount
Short term deposit
Fair Value Hierarchy and NAV [Axis]
Tower's loans (including current maturities)
Cross currency swap- asset, net position
Cross currency swap liability position
Marketable securities held for sale
Foreign exchange forward and cylinders - liability position
Foreign exchange forward and cylinders - asset position
Foreign Exchange forward and cylinders- liability position
Total assets and liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Estimated fair value
Gross unrealized gains
Gross Unrealized losses
Amortized cost
Due within one year, Amortized cost
Due after one year through five years, Amortized cost
Due within one year, Estimated fair value
Due after one year through five years, Estimated fair value
Amortized cost
Investments with continuous unrealized losses for less than 12 months, Fair value
Investments with continuous unrealized losses for less than 12 months, Unrealized losses
Investments with continuous unrealized losses losses for 12 months or greater, Fair value
Investments with continuous unrealized losses losses for 12 months or greater, Unrealized losses
Total Investments with continuous unrealized losses, Fair value
Total Investments with continuous unrealized losses, Unrealized losses
Related Party [Axis]
Severance pay fund, Israeli employees
Long-term employee liabilties, Israeli employees
Israeli employee termination benefits
Matching contribution (as a percent)
Employee contribution (as a percent)
Cost recognized
Net periodic benefit cost
Service cost
Interest cost
Expected return on the plan's assets
Amortization of prior service costs
Amortization of net loss (gain)
Total net periodic benefit cost
Other changes in plan assets and benefits obligations recognized in other comprehensive income:
Prior service cost for the period
Net loss (gain) for the period
Amortization of transition obligation (asset)
Amortization of prior service costs
Amortization of net gain (loss)
Total recognized in other comprehensive income (loss)
Total recognized in net periodic benefit cost and other comprehensive income (loss)
Weighted average assumptions used:
Discount rate
Expected return on plan assets
Rate of compensation increases
Assumed health care cost trend rates:
Health care cost trend rate assumed for current year
Ultimate rate
Year the ultimate rate is reached
Measurement date
Effect on service cost and interest cost, Increase
Effect on post-retirement benefit obligation, Increase
Effect on service cost and interest cost, Decrease
Effect on post-retirement benefit obligation, Decrease
Change in medical plan related benefit obligation:
Benefit obligation at beginning of period
Benefits paid
Change in medical plan provisions
Actuarial loss (gain)
Benefit obligation end of period
Change in plan assets:
Fair value of plan assets at beginning of period
Actual return on plan assets
Employer contribution
Benefits paid
Fair value of plan assets at end of period
Funded status
Accumulated benefit obligation
Amounts recognized in statement of financial position:
Non-current assets
Current liabilities
Non-current liabilities
Net amount recognized
Health care cost trend rate assumed for next year
Ultimate rate
Year the ultimate rate is reached
Weighted average assumptions used:
Discount rate
Expected return on plan assets
Rate of compensation increases
2019
2020
2021
2022
2023
2024 - 2028
Transition obligation (asset)
Prior service cost
Net actuarial loss (gain)
Investments in mutual funds
Total assets measured at fair value
Funded percentage
Target allocation 2019
Schedule of Operating Leased Assets [Table]
Operating Leased Assets [Line Items]
Rent expenses
Lease term
Future minimum payments of non-cancelable operating building leases
2019
2020
2021
2022
2023
Thereafter
Outstanding capital lease liability
Outstanding capital lease liability, current
Annual interest rate on lease
Future minimum lease payments under capital leases
2019
2020
2021
2022
2023
Cash received for technological license and consultation
Percentage of lease agreement on machinery and equipment
Percentage of capacity allocation
Capacity allocation per month
Capital lease term
Reverse stock split, shares exchanged for one share of common stock
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized, per participant
Vesting period
Vesting percentage
Exercisable period
Awards granted
Awards outstanding
Non-option equity awards granted
Compensation cost
Options outstanding
Number of share options
Outstanding as of beginning of year
Granted
Exercised
Terminated
Forfeited
Outstanding as of end of year
Options exercisable as of end of year
Weighted average exercise price
Outstanding as of beginning of year
Granted
Exercised
Terminated
Forfeited
Outstanding as of end of year
Options exercisable as of end of year
Number of RSU's
Outstanding as of beginning of year
Granted
Converted
Forfeited
Outstanding as of end of year
RSU exercisable as of end of year
Weighted Average Fair Value
Outstanding as of beginning of year
Granted
Converted
Forfeited
Outstanding as of end of year
RSU's exercisable as of end of year
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number outstanding
Outstanding, Weighted-average remaining contractual life
Outstanding, Weighted average exercise price
Number exercisable
Exercisable, Weighted average exercise price
Exercise price, minimum
Exercise price, maximum
The intrinsic value of options exercised
The original fair value of options exercised
The intrinsic value of converted RSU's
The original fair value of converted RSU's
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
The effect of stock- based compensation on the Statement of Operations is as follow:
Total stock-based compensation expense
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Expected life of options
Expected annual volatility
Expected annual volatility, minimum
Expected annual volatility, maximum
Expected dividend yield
Weighted average grant-date fair value
Schedule of Segment Reporting Information, by Segment [Table]
Segment Reporting Information [Line Items]
Percentage
Long-Lived Assets
Concentration Risk [Table]
Concentration Risk [Line Items]
Number of customers
Interest expense
Interest income
Jazz Notes amortization
Changes in fair value (total level 3 changes in fair value of bank loans)
Series G Debentures amortization, related rate differences and hedging results
Debentures Series F accretion and amortization including accelerated accretion
Exchange rate differences
Bank fees and others
Financing
Tax Credit Carryforward [Table]
Tax Credit Carryforward [Line Items]
Enterprise tax rate
Unrecognized tax benefits related to tax return which its statute of limitation may expire in March 2015
Net operating loss carryforwards
Net operating loss carryforwards, annual utilization amount
Effective Statutory tax rate
Effect of tax rate reduction benefit due to net deferred tax liabilities
Preferred income subject tax rate
Percentage of Reund
Amount of Refund
Non-cash income tax benefit
Current tax expense (benefit):
Local
Foreign
Deferred tax expense (benefit):
Local (see F below)
Foreign (see E below)
Income tax expense (benefit)
Profit before taxes
Domestic
Foreign
Net deferred tax asset - current:
Net operating loss carryforward
Employees benefits and compensation
Others
Current deferred tax benefit, gross
Valuation allowance, see F below
Total net current deferred tax asset
Deferred tax asset and liability - long-term:
Deferred tax assets:
Net operating loss carryforward
Employees benefits and compensation
Accruals and reserves
Research and development
Others
Gross deferred tax assets - long-term
Valuation allowance, see F below
Deferred tax assets
Deferred tax liabilities:
Depreciation and amortization
Gain on TPSCo acquisition
Others
Deferred tax liabilities
Presented in long term deferred tax assets
Presented in long term deferred tax liabilities
Beginning balance
Additions for tax positions of current year
Additions for tax positions of current year
Reduction due to statute of limitation of prior years
Reduction of prior years' provision
Expiration of prior years provision due to TJP closure
Additions for tax positions of prior years
Decrease from translation differences
Translation differences
Ending balance
Tax expense computed at statutory rates, see (*) below
Preferred Enterprise benefits
Effect of tax rate change on deferred tax liabilities, net(**)
Effect of different tax rates in different jurisdictions and Preferred Enterprise Benefit
Gain on acquisition
Tax benefits for which deferred taxes were not recorded, see F below
Change in Valuation allowance, see F below
Permanent differences and other, net
Long-term investment
Trade accounts payable
Cost of revenues
Financing expenses
General and Administrative expenses
Other income (expense)
Trade accounts receivable
Amount of accumulated share-based compensation.
This element represents the amount of recognized equity-based compensation related to the Facility Agreement with the banks during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).
Represents the information pertaining to asset impairment.
Bank Loans Currency [Axis]
Capacity allocation.
Capital Notes [Member]
CEO, Chairman and directors [Member]
Disclosure of accounting policy for the classification of liabilities and equity. Includes the treatment of any adjustments based on reclassification of liabilities or equity.
Common shares outstanding, net of treasury stock.
Number of customers included in the concentration risk.
Conversion of convertible debentures into share capital.
Disclosure of accounting policy for convertible debentures.
Cross currency interest rate swap, at fair value, used in hedging of Debentures.
Cross currency swap asset position fair value.
Cross currency swap liability position fair value.
Customer One [Member]
Customer Two [Member]
Represents information pertaining to customer 4 of the entity.
Customer One [Member]
Represents information pertaining to customer 3 of the entity.
Customer Two [Member]
Debentures [Member]
Debentures [Text Block]
Number of installment payments agreed upon in order to repay outstanding debt.
Represents the premium percentage price of original principal amount of debt at which debt can be redeemed by the issuer.
Debt Instrument Repayment Schedule [Axis]
Decrease in basic loss per share due to extension of estimated useful lives.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible accruals and reservs.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other and current.
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other and noncurrent.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.
Represents the amount before allocation of valuation allowances of deferred tax liability attributable to deductible temporary differences from gain on acquisition.
The assumed health care cost trend rate for the current year used to measure the expected cost of benefits covered by the plan (gross eligible charges). This is based upon the annual rate of change in the cost of health care benefits currently provided by the postretirement benefit plan, due to factors other than changes in the composition of the plan population by age and dependency status.
The measurement date for the assumed health care cost trend rate.
The expected return on plan assets.
The ultimate trend rate for health care costs.
Year the ultimate health care cost trend rate is expected to be reached, in CCYY format.
Document And Entity Information [Abstract]
Effect of tax rate change on deferred tax liabilities, net.
Amount of decrease in deferred tax liability due to tax rate reduction, attributable to taxable temporary differences.
This represents the noncurrent liability recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement and postemployment benefit plans.
Employees and directors [Member]
Enterprise tax rate.
Exercise Price Range Four [Member]
Exercise Price Range Three [Member]
Exercise Price Range Two [Member]
Expiration of prior years provision due to TJP closure
Facility Agreement [Member]
Represents inforamtion pertaining to facility infrastructure of entity.
The fair value of options exercised during the period.
The original fair value of RSU's exercised.
Fair value of swap.
Fair value of swap in asset position.
Fair value of swap in liability position (short term).
Fair value of swap in long-term asset.
Fair value of swap in short-term assets.
Fair value of swap in short-term liabilities.
Other financing expenses incurred during the period.
Investment grants received during the period to reduce the cost of fixed assets.
Foreign exchange forward and cylinders liability position fair value.
Gains (losses) on business acquisition.
Health Care Cost Trend Rates [Axis]
Health Care Cost Trend Rates [Domain]
Represents the amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the gain on acquisition of a business.
Represents the amount of increase (decrease) in net profit due to extend of useful life of assets.
Independent Directors Plan [Member]
Represents information pertaining to Israeli Banks.
Israeli Banks, Warrants [Member]
Japanese Yen [Member]
Jazz [Member]
Represents the amount of borrowing capacity utilized under the credit facility.
Loan to TJT [Member]
Fair value adjustments to the carrying value of long-term debt.
Fair value of long-term debt with maturities within the next 12 months.
The fair value amount of total long-term debt.
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year and after. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Long term interest bearing bank deposits.
Long-Term Loans Payable [Text Block].
Maxim Fabrication Facility [Member]
JA Mitsui Leasing Capital Corporation [Member]
New external director [Member]
New Other Directors and New External Director [Member]
New other directors [Member]
Old Plans [Member]
The amount the company has deemed available for each tax return, as of the balance sheet date.
Other Asset Category [Member]
Disclosure of accounting policy for other assets.
The amount of net gain or loss that has been amortized and recognized in other comprehensive income.
The amount of prior service cost that has been amortized and recognized in other comprehensive income.
Other Liabilities [Member]
Total outstanding principal amounts of debentures [Member]
Total outstanding principal amounts of loans [Member]
Percentage of capacity allocation.
Percentage of interests acquired.
Percentage of lease agreement on machinery and equipment .
Periodic Payment Three [Member]
Periodic Payment Two [Member]
Post Sixty Five [Member]
Pre Sixty Five [Member]
Preferred Enterprise benefits.
Preferred income subject tax rate.
The cash inflow associated with the amount received from holders exercising their stock warrants and options.
Proceeds from governmental, corporate, or foundation grants.
The cash inflow from issuance of debentures during the year.
Aggregate investment grants received to reduce the cost of fixed assets as of the balance sheet date.
Represents the reduced depreciation expenses amount due to extend of useful life of assets.
Reduction of prior years' provision.
The amount of other income (expense) pertaining to related party transactions during the period.
The cash outflow to settle a debentures during the year.
Restructuring and impairment charges, net.
Tabular disclosure about the outstanding balance of accounts receivable from major customers, presented as a percentage of the aggregate accounts receivable balance.
Tabular disclosure of the estimated useful lives used to caluculate depreciation of assets.
Tabular disclosure of leased property under capital leases.
Schedule of Marketable Securities.
Tabular disclosure of maturities of marketable securities.
Tabular disclosure of the total intrinsic value of restricted stock units exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.
Series 9 [Member]
Fund for the liability for severance pay benefits for severance and pension, funded by regular employer deposits and compay maintained insurance policies.
Severance pay fund related to Israeli employees.
The number of equity-based payment instruments, excluding stock (or unit) options, exercisable as of the balance sheet date.
The weighted average fair value of equity-based payment instruments, excluding stock (or unit) options, exercisable as of the balance sheet date.
The number of equity-based payment instruments, excluding stock (or unit) options, exercised during the period.
The weighted average fair value of equity-based payment instruments, excluding stock (or unit) options, exercised during the period.
The maximum number of shares (or other type of equity) originally approved per individual (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
Short-term bank debt and convertible notes payable, current.
Stock-based Instruments, Policy [Policy Text Block]
Number of shares exchanged for one share of common stock.
Tabular disclosure of the effect of the adoption of ASC 815-40 on equity and retained earnings.
TPSCo [Member]
Tacoma [Member]
Technologies [Member]
Represents the information pertaining to technologies one.
Represents the information pertaining to technologies two.
Represents information pertaining to 2014 Term Loan.
Represents information pertaining to 2015 Term Loan.
Options vesting on the third anniversary from grant date.
Time Vested Restricted Stock Units [Member]
TJT [Member]
TIBOR [Member]
Jazz Debentures [Member]
Tower Jazz Japan Limited [Member]
Represents information pertaining to TowerJazz Panasonic Semiconductor Company, Ltd.
Tower U.S. Holdings [Member]
2014 Notes [Member].
Two Thousand Nine Employee Share Incentive Plan [Member]
2007 Non-Convertible Debentures Series D [Member]
2010 Convertible Debentures Series F [Member]
Debentures Series G [Member]
2010 Notes [Member]
2013 Share Incentive Plan [Member]
United States Dollars [Member]
Warrants J [Member]
Warrants 7 [Member]
Disclosure of accounting policy pertaining to new accounting pronouncements adopted that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the sixth fiscal year and after. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
One customer [Member]
Term Loan 2018 [Member]
Second Anniversary [Member]
First Anniversary [Member]
Percentage of Reund.
Non-cash income tax benefit.
Reduction due to statute of limitation of prior years.
Other financing expense, net.
Exercise of options and Restricted Stock Units.
Number of shares issued from exercise of options and Restricted Stock Units.
Unearned employee stock-based compensation.
Tower Jazz Panasonic Semiconductor Company Ltd [Member]
Inventory, Net
Assets, Current
Assets
Liability, Pension and Other Postretirement and Postemployment Benefits, Current
Liabilities, Current
Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent
Liabilities
Stockholders' Equity before Treasury Stock
Treasury Stock, Value
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Net Income (Loss) Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Parent
Earnings Per Share, Diluted
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax
Shares, Outstanding
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Dividends
Conversion of Notes to Share Capital
Foreign Currency Transaction Gain (Loss), before Tax
Other Noncash Income (Expense)
Business Combination, Bargain Purchase, Gain Recognized, Amount
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Inventories
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Deferred Revenue
Increase (Decrease) in Deferred Income Taxes
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Intangible Assets
Payments to Acquire Other Productive Assets
Net Cash Provided by (Used in) Investing Activities
Repayments of Bank Debt
Capital Lease Obligations Incurred
Repayments of Debentures
Payments of Ordinary Dividends, Noncontrolling Interest
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Conversion Of Convertible Debentures Into Share Capital And Exercise Of Warrant
Inventory Disclosure [Text Block]
Other Current Assets [Text Block]
Cost and Equity Method Investments Disclosure [Text Block]
Property, Plant and Equipment Disclosure [Text Block]
Intangible Assets Disclosure [Text Block]
Other Assets Disclosure [Text Block]
Other Liabilities Disclosure [Text Block]
Pension and Other Postretirement Benefits Disclosure [Text Block]
Other Income and Other Expense Disclosure [Text Block]
Income Tax Disclosure [Text Block]
Cash and Cash Equivalents, Policy [Policy Text Block]
Marketable Securities, Policy [Policy Text Block]
Inventory, Policy [Policy Text Block]
Other Assets [Policy Text Block]
Research and Development Expense, Policy [Policy Text Block]
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Noncurrent
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation
Capital Leases, Balance Sheet, Assets by Major Class, Net
Finite-Lived Intangible Assets, Accumulated Amortization
Other Accrued Liabilities, Current
Long-term Debt
Debt Instrument, Unamortized Discount
Long Term Debt Fair Value Adjustments
Debt Issuance Costs, Net
Long Term Debt Fair Value Total
Long Term Debt Fair Value Current
Debt Instrument, Interest Rate, Basis for Effective Rate
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred
Cumulative Effect Adjustment of Facility Agreement to Retained Earnings
Foreign Currency Contracts, Liability, Fair Value Disclosure
Fair Value, Net Asset (Liability)
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss
Defined Benefit Plan, Expected Return (Loss) on Plan Assets
Defined Benefit Plan, Amortization of Gain (Loss)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent
Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax
Defined Benefit Plan, Effect of One Percentage Point Decrease on Service and Interest Cost Components
Defined Benefit Plan, Effect of One Percentage Point Decrease on Accumulated Postretirement Benefit Obligation
Defined Benefit Plan, Benefit Obligation
Defined Benefit Plan, Benefit Obligation, Benefits Paid
Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)
Defined Benefit Plan, Plan Assets, Amount
Defined Benefit Plan, Plan Assets, Benefits Paid
Defined Benefit Plan, Funded (Unfunded) Status of Plan
Defined Benefit Plan, Accumulated Benefit Obligation
Liability, Defined Benefit Pension Plan, Current
Liability, Defined Benefit Pension Plan, Noncurrent
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Expected Return On Plan Assets
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase
Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months
Defined Benefit Plan, Expected Future Benefit Payment, Year Two
Defined Benefit Plan, Expected Future Benefit Payment, Year Three
Defined Benefit Plan, Expected Future Benefit Payment, Year Four
Defined Benefit Plan, Expected Future Benefit Payment, Year Five
Operating Leases, Future Minimum Payments Due, Next Twelve Months
Operating Leases, Future Minimum Payments, Due in Two Years
Operating Leases, Future Minimum Payments, Due in Three Years
Operating Leases, Future Minimum Payments, Due in Four Years
Operating Leases, Future Minimum Payments, Due in Five Years
Capital Leases, Future Minimum Payments Due, Next Twelve Months
Capital Leases, Future Minimum Payments Due in Two Years
Capital Leases, Future Minimum Payments Due in Three Years
Capital Leases, Future Minimum Payments Due in Four Years
Capital Leases, Future Minimum Payments Due Thereafter
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Exercisable Number
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments other than Options Exercised in Period Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other than Options Exercisable Weighted Average Grant Date Fair Value
Interest and Other Income
Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss)
Financing Expense Other
OtherFinancingExpenseNet
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Income (Loss) from Continuing Operations before Income Taxes, Foreign
Document and Entity Information [Abstract] [Default Label]
Deferred Tax Assets, Gross, Current
Deferred Tax Assets, Valuation Allowance, Current
Deferred Tax Assets, Net of Valuation Allowance, Current
Deferred Tax Assets Operating Loss Carryforwards Noncurrent
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Noncurrent [Default Label]
Deferred Tax Assets, in Process Research and Development
Facility Agreement [Member]
Deferred Tax Assets, Gross, Noncurrent
Deferred Tax Assets, Valuation Allowance, Noncurrent
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
Deferred Tax Liabilities, Property, Plant and Equipment
Deferred Tax Liability, Gain on Acquisition
Deferred Tax Liabilities, Other
Deferred Tax Liabilities, Net
Deferred Tax Liabilities, Gross
Unrecognized Tax Benefits
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Increase (Decrease) in Net Profit Due to Extend of Useful Life of Assets
Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation
Schedule Of Accounts Receivable Balance By Major Customers [Table Text Block]
Fixed Asset Investment Grants
Income Tax Reconciliation Gain on Acquisition of Business
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Accounts Payable, Related Parties, Current
Related Party Transaction, Purchases from Related Party
Related Party Transaction Other Income Expense
Accounts Receivable, Related Parties, Current